Views & Analysis Why AI and blockchain are the solutions to developing orphan... We are in the midst of a significant shift in pharmaceutical drug development, with many leading companies focusing increasingly on orphan drugs targeted at small niche markets.
Views & Analysis Why blockchain is a dream come true for pharma researchers Researchers tend to have a genuine scientific curiosity and desire to make the world better with their discoveries.
Views & Analysis Four steps to building an innovation culture in pharma The quest for innovation is a major driving force in pharma.
Views & Analysis How blockchain will revolutionise clinical trials The risky and unpredictable nature of the clinical trial process is a major driver of high costs for pharmaceutical drugs.
Views & Analysis To unlock innovation, pharma needs to be honest about failur... Many successful leaders agree that a company’s willingness to embrace and learn from failure can unlock inn
News Sanofi gives up on amlitelimab in atopic dermatitis Sanofi has stopped development of anti-OX40L drug amlitelimab in atopic dermatitis, a major blow to what was once viewed as a 'pipeline-in-a-product'.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.